Hudock Inc’s Emergent Biosolutions EBS Stock Holding History

Hudock Inc’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15	Closed	-$1K	–	814
2021 Q1	$1K	Hold	15	–	–	﹤0.01%	768
2020 Q4	$1K	Hold	15	–	–	﹤0.01%	721
2020 Q3	$1K	Buy	+15	New	+$1.62K	﹤0.01%	698

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudock Inc's EBS Position: Q2 2021 in Review

Hudock Inc sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 15 shares — an estimated $1K sold.

Hudock Inc first reported a position in EBS in Q3 2020 and held it in 3 quarters. The position peaked at $1K in Q1 2021. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Hudock Inc reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Hudock Inc sold 15 Emergent Biosolutions shares in Q2 2021, an estimated $1K.
Hudock Inc first reported a position in Emergent Biosolutions in Q3 2020 and held it in 3 quarters.
Hudock Inc's Emergent Biosolutions position peaked at $1K in Q1 2021.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Hudock Inc's 13F filing for Q2 2021, filed 9 Aug 2021.